As taxas de prevalência de pólipos nasais na população adulta em geral estão provavelmente entre 2% e 4%; cerca de 7% das pessoas com asma também têm rinossinusite crônica com pólipos nasais.[3]Langdon C, Mullol J. Nasal polyps in patients with asthma: prevalence, impact, and management challenges. J Asthma Allergy. 2016 Mar 14;9:45-53.
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4798207
http://www.ncbi.nlm.nih.gov/pubmed/27042129?tool=bestpractice.com
[4]Rank MA, Chu DK, Bognanni A, et al. The Joint Task Force on Practice Parameters GRADE guidelines for the medical management of chronic rhinosinusitis with nasal polyposis. J Allergy Clin Immunol. 2023 Feb;151(2):386-98.
https://www.jacionline.org/article/S0091-6749(22)01484-1/fulltext
http://www.ncbi.nlm.nih.gov/pubmed/36370881?tool=bestpractice.com
A sinusite crônica afeta 5% a 12% da população em geral.[2]Fokkens WJ, Lund VJ, Hopkins C, et al. European position paper on rhinosinusitis and nasal polyps 2020. Rhinology. 2020 Feb 20;58(suppl s29):1-464.
http://www.ncbi.nlm.nih.gov/pubmed/32077450?tool=bestpractice.com
Os pólipos nasais estão presentes em aproximadamente 25% a 30% dos pacientes com rinossinusite crônica.[5]Stevens WW, Schleimer RP, Kern RC. Chronic rhinosinusitis with nasal polyps. J Allergy Clin Immunol Pract. 2016 Jul-Aug;4(4):565-72.
http://www.ncbi.nlm.nih.gov/pubmed/27393770?tool=bestpractice.com
Os pólipos nasais são mais comuns em homens que em mulheres. A média de idade do início é aproximadamente 42 anos.[5]Stevens WW, Schleimer RP, Kern RC. Chronic rhinosinusitis with nasal polyps. J Allergy Clin Immunol Pract. 2016 Jul-Aug;4(4):565-72.
http://www.ncbi.nlm.nih.gov/pubmed/27393770?tool=bestpractice.com
Eles são menos comumente encontrados em pessoas com menos de 18 anos.[4]Rank MA, Chu DK, Bognanni A, et al. The Joint Task Force on Practice Parameters GRADE guidelines for the medical management of chronic rhinosinusitis with nasal polyposis. J Allergy Clin Immunol. 2023 Feb;151(2):386-98.
https://www.jacionline.org/article/S0091-6749(22)01484-1/fulltext
http://www.ncbi.nlm.nih.gov/pubmed/36370881?tool=bestpractice.com
A maior prevalência está em indivíduos com asma, com fibrose cística e com hipersensibilidade à aspirina ou a anti-inflamatórios não esteroidais, comparado à população em geral.[3]Langdon C, Mullol J. Nasal polyps in patients with asthma: prevalence, impact, and management challenges. J Asthma Allergy. 2016 Mar 14;9:45-53.
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4798207
http://www.ncbi.nlm.nih.gov/pubmed/27042129?tool=bestpractice.com
[6]Philpott CM, Erskine S, Hopkins C, et al. Prevalence of asthma, aspirin sensitivity and allergy in chronic rhinosinusitis: data from the UK National Chronic Rhinosinusitis Epidemiology Study. Respir Res. 2018 Jun 27;19(1):129.
https://respiratory-research.biomedcentral.com/articles/10.1186/s12931-018-0823-y
http://www.ncbi.nlm.nih.gov/pubmed/29945606?tool=bestpractice.com
[7]Johnson BJ, Choby GW, O'Brien EK. Chronic rhinosinusitis in patients with cystic fibrosis - current management and new treatments. Laryngoscope Investig Otolaryngol. 2020 Jun;5(3):368-74.
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7314487
http://www.ncbi.nlm.nih.gov/pubmed/32596478?tool=bestpractice.com